Immanual John Milton Bloomberg

AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.

As the crypto winter deepens, only the staunchest Bitcoin investors are still holding onto their tokens -- but not on the exchanges.

AstraZeneca Plc's ambitions for developing an easier formulation of its Covid-19 vaccine -- one that might help curb contagion as well -- suffered a setback Monday as the nasal spray failed in an early test.

As the crypto winter deepens, only the staunchest Bitcoin investors are still holding onto their tokens -- but not on the exchanges.